NDC 27241-290 – Terazosin

Terazosin Hydrochloride 5 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC27241-290

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Ajanta Pharma USA Inc.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA219482
Marketed since
May 12, 2025
Listing expires
December 31, 2027
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (2)

Package NDCDescriptionSince
27241-290-01100 CAPSULE in 1 BOTTLE (27241-290-01)May 12, 2025
27241-290-101000 CAPSULE in 1 BOTTLE (27241-290-10)May 12, 2025

Other Terazosin products